- Home
- TLPH vs EKSO Comparison
TLPH vs EKSO Comparison
Compare TLPH & EKSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLPH
- EKSO
- Stock Information
- Founded
- TLPH 2005
- EKSO 2005
- Country
- TLPH United States
- EKSO United States
- Employees
- TLPH N/A
- EKSO N/A
- Industry
- TLPH Biotechnology: Pharmaceutical Preparations
- EKSO Medical/Dental Instruments
- Sector
- TLPH Health Care
- EKSO Health Care
- Exchange
- TLPH Nasdaq
- EKSO Nasdaq
- Market Cap
- TLPH 10.6M
- EKSO 11.7M
- IPO Year
- TLPH 2011
- EKSO N/A
- Fundamental
- Price
- TLPH $0.44
- EKSO $2.82
- Analyst Decision
- TLPH Strong Buy
- EKSO Strong Buy
- Analyst Count
- TLPH 1
- EKSO 2
- Target Price
- TLPH $6.00
- EKSO $37.50
- AVG Volume (30 Days)
- TLPH 31.7K
- EKSO 238.2K
- Earning Date
- TLPH 08-13-2025
- EKSO 07-28-2025
- Dividend Yield
- TLPH N/A
- EKSO N/A
- EPS Growth
- TLPH N/A
- EKSO N/A
- EPS
- TLPH N/A
- EKSO N/A
- Revenue
- TLPH $27,000.00
- EKSO $17,544,000.00
- Revenue This Year
- TLPH N/A
- EKSO $0.20
- Revenue Next Year
- TLPH $14,533.26
- EKSO $42.29
- P/E Ratio
- TLPH N/A
- EKSO N/A
- Revenue Growth
- TLPH N/A
- EKSO N/A
- 52 Week Low
- TLPH $0.44
- EKSO $2.82
- 52 Week High
- TLPH $1.19
- EKSO $22.95
- Technical
- Relative Strength Index (RSI)
- TLPH 31.91
- EKSO 20.84
- Support Level
- TLPH $0.45
- EKSO $3.75
- Resistance Level
- TLPH $0.52
- EKSO $4.03
- Average True Range (ATR)
- TLPH 0.03
- EKSO 0.35
- MACD
- TLPH -0.00
- EKSO -0.07
- Stochastic Oscillator
- TLPH 0.00
- EKSO 0.00
About TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.
About EKSO Ekso Bionics Holdings Inc.
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.